4.6 Article

Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer

Related references

Note: Only part of the references are listed.
Review Oncology

Role of Platinums in Triple-Negative Breast Cancer

Filipa Lynce et al.

Summary: Platinum compounds are an option in the treatment of TNBC, but biomarkers are still needed to predict response to these agents.

CURRENT ONCOLOGY REPORTS (2021)

Article Immunology

Polyfunctional KLRG-1+CD57+ Senescent CD4+ T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients

Maria C. Ramello et al.

Summary: Senescent T cells with inhibitory receptor expression produce more effector cytokines and exhibit higher expression of key proteins, suggesting an active role in immune responses. Transcriptional profiling of senescent CD4(+) T-cells reveals enrichment in genes associated with cytotoxicity and cell exhaustion compared to non-senescent T cells. High expression of certain genes correlates with increased overall survival in breast cancer patients, indicating the potential utility of assessing senescent T cells as a biomarker.

FRONTIERS IN IMMUNOLOGY (2021)

Article Audiology & Speech-Language Pathology

An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity

K. Fernandez et al.

HEARING RESEARCH (2019)

Article Endocrinology & Metabolism

The hypothalamus-pituitary-gonad axis: Tales of mice and men

Athina Kaprara et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2018)

Review Chemistry, Medicinal

LHRH-Targeted Drug Delivery Systems for Cancer Therapy

Xiaoning Li et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)

Article Oncology

99mTc-LHRH in tumor receptor imaging

Dawei Hao et al.

ONCOLOGY LETTERS (2017)

Review Obstetrics & Gynecology

GnRH and GnRH receptors in the pathophysiology of the human female reproductive system

Roberto Maggi et al.

HUMAN REPRODUCTION UPDATE (2016)

Review Pharmacology & Pharmacy

Cisplatin in cancer therapy: Molecular mechanisms of action

Shaloam Dasari et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Review Pharmacology & Pharmacy

Carboplatin: molecular mechanisms of action associated with chemoresistance

Graziele Fonseca de Sousa et al.

BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)

Article Medicine, Research & Experimental

LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer

Natalia V. Nukolova et al.

MOLECULAR PHARMACEUTICS (2013)

Article Pharmacology & Pharmacy

The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice

Azade Taheri et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)

Review Biochemistry & Molecular Biology

Molecular mechanisms of cisplatin resistance

L. Galluzzi et al.

ONCOGENE (2012)

Review Medicine, General & Internal

Triple-Negative Breast Cancer

William D. Foulkes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

Mary Jo Lund et al.

BREAST CANCER RESEARCH AND TREATMENT (2009)

Review Oncology

Breast Cancer Before Age 40 Years

Carey K. Anders et al.

SEMINARS IN ONCOLOGY (2009)

Article Cell Biology

Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo

William Hansel et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)

Review Agriculture, Dairy & Animal Science

GnRH in non-hypothalamic reproductive tissues

N Ramakrishnappa et al.

ANIMAL REPRODUCTION SCIENCE (2005)